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Introduction: As a topical delivery system, a nanoscaled emulsion is considered a good carrier 
of several active ingredients that convey several side effects upon oral administration, such as 
nonsteroidal anti-inflammatory drugs (NSAIDs).
Objective: We investigated the in vitro permeation properties and the in vivo pharmacodynamic 
activities of different nanoscaled emulsions containing ibuprofen, an NSAID, as an active 
ingredient and newly synthesized palm olein esters (POEs) as the oil phase.
Methodology: A ratio of 25:37:38 of oil phase:aqueous phase:surfactant was used, and 
  different additives were used for the production of a range of nanoscaled emulsions.   Carbopol® 
940 dispersion neutralized by triethanolamine was employed as a rheology modifier. In some 
circumstances, menthol and limonene were employed at different concentrations as permeation 
promoters. All formulae were assessed in vitro using Franz diffusion cell fitted with full-thickness 
rat skin. This was followed by in vivo evaluation of the anti-inflammatory and analgesic activities 
of the promising formulae and comparison of the effects with that of the commercially available 
gel.
Results and discussion: Among all other formulae, formula G40 (Carbopol® 940-free 
formula) had a superior ability in transferring ibuprofen topically compared with the   reference. 
Carbopol® 940 significantly decreased the amount of drug transferred from formula G41 
through the skin as a result of swelling, gel formation, and reduction in drug thermodynamic 
activity. Nonetheless, the addition of 10% w/w of menthol and limonene successfully overcame 
this drawback since,   relative to the reference, higher amount of ibuprofen was transferred 
through the skin. By contrast, these results were relatively comparable to that of formula G40. 
  Pharmacodynamically, the G40, G45, and G47 formulae exhibited the highest anti-inflammatory 
and analgesic effects compared with other formulae.
Conclusion: The ingredients and the physical properties of the nanoscaled emulsions produced 
by using the newly synthesized POEs succeeded to deliver ibuprofen competently.
Keywords: in vivo analgesic, anti-inflammatory effects
Introduction
Skin, the biggest organ in the body that accounts for about 10% of total bodyweight, 
provides several functions, which are: protection, thermoregulation, transpiration, 
homeostasis, and sensation.1 Physiologically, skin is the thickest barrier of the body 
and consists of three major layers; namely, the epidermis or outer layer, the dermis, and 
the subcutaneous tissues or hypodermis.1–4 Stratum corneum, the most superficial layer 
of the epidermis,5,6 represents the nonviable part that comprises many layers of dead 
and nucleus-free cells, known as corneocytes. It is the main barrier for both ingress 
and egress of materials and/or many environmental contaminants and foreign bodies.7 International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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This property is attributed to the stratum corneum exceptional 
brick wall-like structure comprising corneocytes as the bricks 
and intercellular lipids as the mortar.5,8,9
Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), 
possesses analgesic, antipyretic and anti-inflammatory 
activities. As a propionic acid derivative, ibuprofen has a 
short half-life of only 2.2 hours and a high level (90%–99%) 
of plasma protein binding.10 Hence, its plasma concentration 
reaches the peak level after approximately 1–2 hours 
  following its oral administration, with a subsequent rapid 
excretion in the urine. Ibuprofen is a water-insoluble drug 
with an acidic pKa value of 5.3 and high lipophilicity with 
a log P value of 3.6.
It was suggested by many researchers that a relatively 
high partition coefficient can reduce drugs’ skin permeation 
due to the elevated lipophilicity, which may cause them to 
be deposited in the skin lipid layers, particularly the stratum 
corneum. However, this accumulation is useful when 
localized effects are required. Therefore, several   techniques 
were performed to improve the transdermal transport 
of ibuprofen, such as complexation with cyclodextrin,11 
supersaturation,12,13 preparation of colloidal microstructures 
with lysinate and lecithin,14 eutectic systems produced by 
melting-point depression,15,16 iontophoresis,17 and the usage 
of surfactants and various vehicles.18,19
Nanoscaled emulsion and microemulsion possess very 
small droplets size,20–23 which makes them quite appealing 
for the topical delivery of various drugs. They have the ability 
to accommodate large amounts of drug due to the increased 
solubilization capacity, thereby enhancing the   thermodynamic 
activity towards the skin. Furthermore, the main constituents 
of these biphasic systems can be   combined synergistically to 
enhance drug flux.24
Skin hydration is known to enhance transdermal drug 
delivery; therefore, many efforts have been made to synthe-
size various compounds capable of boosting skin hydration. 
Palm olein esters (POEs), a modified form of palm oil, was 
synthesized by a Malaysian research group by reacting 
palm oil with olyel alcohol to produce long ester chains of 
the original triglyceride palm oil. It is reported that POEs 
have a skin hydration activity of 40.7% after 90 minutes of 
application.25
Terpenes, as penetration enhancers, are essential oils 
obtained from natural sources; they are thus classified by 
the United States Food and Drug Administration as safe and 
effective sorption promoters. Isoprene (C5H8) is the building 
block of these materials and is usually repeated and joined 
together from head to tail.26,27 Terpenes, compared with 
surfactants and other types of enhancers, are safer, less toxic, 
and less irritating.28
In general, terpenes are classified, according to the number 
of isoprene units, into: monoterpens (C10), sesquiterpenes 
(C15), diterpenes (C20), sesterterpenes (C25), triterpenes 
(C30), and tetraterpenes (C40). Menthol and limonene are 
both monoterpenes, but they are chemically different. Menthol 
is an ester-alcohol terpene, while limonene is hydrocarbon 
lipophilic terpene. Terpenes act as good permeation promoters 
as they are highly lipophilic, able to disrupt skin lipid packing, 
and capable of forming eutectic mixtures.26,29
In the present study, we investigated the suitability of 
using these newly introduced POEs as an internal phase 
for topical delivery of ibuprofen in nanoscaled emulsion 
formulations. We further examined the effect of various con-
centrations and types of terpenes as permeation promoters. 
In view of that, attempts have been made to compare the 
potential activity of the formulated nanoscaled emulsions to 
topically deliver ibuprofen with that of the marketed formula. 
Experimentally, we evaluated the in vitro transfer of the 
prepared formulae through full-thickness rat skin using a 
marketed gel formula as a reference. Moreover, the in vivo 
anti-inflammatory and analgesic activities of the tested and 
the commercially available preparations were measured and 
compared.
Materials and methods
Materials
Potassium dihydrogen phosphate and sodium hydroxide 
were supplied by R and M Chemicals (London, UK). 
Orthophosphoric and hydrochloric acids were supplied by 
BDH (London, UK). Acetonitrile and methanol, high perfor-
mance liquid chromatography (HPLC) grade, were purchased 
from JT Baker (Phillipsburg, NJ). The POEs were a contri-
bution from co-researchers at the Universiti Putra Malaysia 
(Selangor, Malaysia). Tween 80, Tween 85, Span 20, Span 85, 
and sodium benzoate were purchased from Sigma-Aldrich 
Chemie, GmbH (Munich, Germany). Ibuprofen was supplied 
by Noveltek Life-Science (Tanggu, China). Menthol and 
limonene were supplied by Sigma-Aldrich Chemie, GmbH 
(Munich, Germany). Nurofen® 5% gel was obtained by Boots 
Healthcare International (London, UK). All other solvents 
were of analytical grade.
Methods
Preparation of the nanoscaled emulsions
Preliminary studies by our research group were initially carried 
out to determine the best POE–surfactant–  mixture compositions International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that can provide the highest drug   solubility and preferred 
physical properties of o/w   emulsions (data not shown). 
This was achieved via constructing several pseudoternary 
phase diagrams and followed by the characterization of the 
selected formulae in terms of appearance, droplets size, 
flow properties, zeta potential, and physical stability upon 
standing. A few nanoscaled emulsions were chosen for further 
investigation. These formulae (Table 1) contained POEs as the 
oil phase,   triethanolamine (TEA) aqueous solution pH 7.4 as 
the aqueous external phase, and Tween 80 (HLB 15) as the 
emulsifying agent. Sodium benzoate and Carbopol® 940 were 
used as a   preservative and rheology modifier, respectively. 
A ratio of 25:37:38 of POEs:aqueous phase:Tween 80 was 
chosen for the production of pharmaceutically acceptable 
nanoscaled emulsions for topical delivery.
The preparation process of the nanoscaled emulsions 
was conducted by initially mixing the specified ratios of the 
oil phase (POEs) and the emulsifier in a beaker under the 
  following conditions: mixing at a speed of 750 rpm using low 
shear mixer equipped with a three-blade propeller and temper-
ature control of 40°C ± 1°C for 30 minutes. Subsequently, 
5% w/w of ibuprofen was dissolved, and the resultant mixture 
was further revolved at the same speed and temperature for 
another 30 minutes. The external phase (pH 7.4) controlled 
by TEA and containing 0.20% w/w sodium benzoate and 
0.50% w/w of Carbopol® 940 was added separately drop 
by drop with continuous stirring for another 90 minutes. 
  Agitation using the low shear mixer at a rotation speed of 
1500 rpm was then used for approximately 4–5 hours to ensure 
the formation of homogenous nanoscaled emulsions.
In vitro transport of drug through rat skin
In this study, full thickness Wistar Kyoto rat skin was used 
to assess the in vitro drug transport. Franz-type diffusion 
cell (PermeGear, Inc, Hellertown, PA) vertically situated 
with an effective diffusion area of 0.636 cm2 and a receptor 
cell volume of 5 mL was used. Skin samples were obtained 
from the abdominal region of healthy 200–250 g male rats. 
All experimental procedures on animals were in accordance 
with the Guidelines of the Animal Ethical Committee of the 
Universiti Sains Malaysia (USM) and had their approval 
(Reference number: USM/PPSF/50 [042] Jld.2).
Rats were initially anesthetized with 60 mg/kg sodium 
pentobarbitone injection given intraperitoneally. The abdom-
inal skin was first shaved using electric and hand razors and 
then surgically excised from the animal. The skin removal 
step was followed by carefully removing the adhering sub-
cutaneous fat from the skin. To remove the extraneous debris 
and leachable enzymes, the cleaned skin was immersed and 
periodically flushed with normal saline solution for 2 hours. 
Finally; the pieces of cleaned skin were washed with distilled 
water and wrapped in aluminum foil and stored in a deep 
freezer at −20°C. After freezing, the skin was cut into 0.15 cm 
thick pieces and kept at the same temperature to be used the 
next day when the experiment was performed.
On the day of experimentation, the appropriate number 
of frozen skin pieces were thawed at room temperature and 
mounted between the donor and the receptor compartments 
of the diffusion cell with the stratum corneum side facing the 
donor compartment and the dermal side facing the receptor 
compartment. The static receptor cell was filled with 5 mL 
0.2 M phosphate buffer solution (PBS) pH 7.430 and kept at 
37°C ± 0.5°C by a circulating water jacket. The content of the 
receptor compartment was continuously stirred at 500 rpm 
using a small magnetic bar to ensure its uniformity over the 
time course of the experiment.
A quantity of 100 mg of each formulation tested was 
placed in the donor compartment and spread evenly on the 
full-thickness rat skin, and the cells were finally covered 
with aluminum foil. Samples of 400 µL were withdrawn at 
predetermined time intervals of 0.5, 1, 2, 3, 4, 6, and 8 hours, 
and replaced with the same volume of fresh PBS pH 7.4 kept 
at 37°C. Sink conditions were met in all cases and triplicate 
parallel determinations were performed using skin taken from 
Table 1 chemical composition (% w/w) of selected nanoscaled emulsions
Formula Ibuprofen  
content
Oil phase TEA solution  
pH 7.4
Tween 80
Menthol Limonene POEs
g40a 5 – 23.70 35.08 36.02
g41 5 – 23.58 34.89 35.83
g44 5 5 – 18.58 34.89 35.83
g45 5 10 – 13.58 34.89 35.83
g46 5 – 5 18.58 34.89 35.83
g47 5 – 10 13.58 34.89 35.83
Note: All formulations contain 0.20% w/w sodium benzoate as a preservative and 0.50% w/w carbopol® 940 as a rheology modifier. acarbopol® 940-free nanoscaled emulsion.
Abbreviations: POe, palm olein ester; TeA, triethanolamine.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
390
Abdullah et al
the same rat. Dilution of samples with the HPLC mobile 
phase was made when necessary, and the drug content in the 
collected samples was then determined by a validated HPLC 
method modified by our research team.31
calculation of permeability parameters
Parameters were calculated in this part of the study to 
compare the drug transfer and permeation properties amongst 
the tested formulae. Descriptions of these parameters are 
outlined below and include steady state flux, permeability 
coefficient, and enhancement ratio.
Steady state flux
Flux is defined as the rate of diffusion or transport of a sub-
stance through a permeable membrane. After reaching the 
steady state of drug permeation, flux was calculated using 
the following equation:
  Steady state flux (Jss) = dM/S ⋅ dt,  (1)
where dM is the amount of drug that permeates through a 
unit cross-section area (S) in a unit time (t). From the above 
equation, it is clear that the slope of the steady state portion 
of the permeation curve created by plotting the cumulative 
amount of drug permeated in micrograms versus time in 
hours is the flux.32
Permeability coefficient
The quantity of ibuprofen diffused per unit area of skin 
(dM/S) was calculated for each time interval, and the 
permeability coefficient through the membrane (Kp) was 
determined according to the following equation:
  Permeability coefficient (Kp) = (Jss ⋅ H)/C0,  (2)
where Jss is the steady state flux, H is the thickness of mem-
brane used, and C0 is the initial drug concentration.
enhancement ratio
The enhancement ratio was calculated to find the relative 
enhancement in the flux of formulations evaluated with 
respect to reference enhancement ratio. The enhancement 
ratio was estimated according to the following equation:
 Enhancement ratio (Er) = Jss formulation/Jss reference. (3)
Measurement of in vivo anti-inflammatory activity
Healthy male Sprague Dawley rats weighing 180–200 g 
were used in this study. All experimental procedures on 
animals conformed to the Guidelines of the Animal   Ethical 
committee of USM and had their approval (Reference 
number: USM/PPSF/50 [042] Jld.2). The anti-inflammatory 
action was evaluated by using the carrageenan-induced hind 
paw edema method as reported by Larson and Lombardino.33 
Rats were randomly picked and divided into five groups of 
six animals each for administering the control (ibuprofen-
free formula), formulations G40, G45, and G47, as well as 
the reference product (Nurofen® 5% Gel). The animals were 
housed in polypropylene cages at 25°C ± 1°C and 60% ± 5% 
relative humidity, with free access to food and water.
On the test day, 100 mg of formulations G40, G45, G47, 
reference, and the control were rubbed gently into the right 
hind paw (hairless legs) until complete disappearance of the 
amount applied. After 1 hour, 0.1 mL of 1% w/v carrageenan 
suspension was injected into the subplantar region of the 
right hind paws of controlled and treated groups. This was 
followed by measuring the edema volume via determining 
paw thickness at fixed time intervals of 1, 2, 3, 4, 5, and 
6 hours. All measurements were achieved at 25°C ± 1°C 
in an air-conditioned room using a micrometer (Ozaki Ltd, 
Okayama, Japan).34,35 The induced swelling was measured 
by placing the foot of the rat in between the anvil and the 
spindle of the micrometer. The degree of swelling induced 
by carrageenan was calculated as a percentage of hind paw 
thickness at the intervals specified relative to their initial 
thickness. Mathematically, the degree of swelling was calcu-
lated as follows:
 
Percentagechanges
of hindpawthickness
=
−
×
cc
c
t 100%,
 
(4)
where ct = hind paw thickness at 1, 2, 3, 4, 5, and 6 hour 
intervals after injecting carrageenan. c = initial hind paw 
thickness, ie, before the injection of carrageenan.
Measurement of in vivo analgesic activity
In this study, a procedure similar to that mentioned in the 
previous section was utilized with the exception of measuring 
the pain threshold response of the right hind paw instead of the 
edematous thickness. The pain threshold was measured initially 
before injecting the inflammatory inducer (  carrageenan) and 
at preset time intervals of 2 and 4 hours following the applica-
tion of 100 mg of the control (ibuprofen-free formula), formu-
lations G40, G45, and G47, as well as the reference product 
(Nurofen® 5% Gel). All measurements were performed in an International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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air-conditioned room at controlled temperature of 25°C ± 1°C 
using a portable pain threshold device (YMF-P1) equipped 
with data   acquisition system (fabricated by the Department 
of Pharmacology, School of Pharmaceutical Sciences, USM, 
Malaysia). The pain threshold was measured as the pressure 
in grams applied on the edematous hind paw which caused 
the rat to withdraw the treated paw. The vocalization or the 
struggles of the rat were also considered as indicators for the 
pain threshold.36 The change in pain threshold was calculated 
as the   difference in the pain threshold before and after the 
injection of carrageenan.
statistical analysis
The statistical analysis of the data obtained was performed 
using SPSS software (version 16; SPSS Inc., Chicago, IL). 
One-way ANOVA test was used to measure the statistical 
difference between tested formulae, where the difference 
was considered statistically significant at P , 0.05 and 
P , 0.001.
Results and discussion
Drug transfer through rat skin
Initially, two formulae G40 and G41 were chosen to be 
tested and compared with the reference formula (  Nurofen® 
5% Gel). This selection was based on the characterization 
of the results obtained at an earlier stage of this work. 
Formulation G40 showed the highest ibuprofen   solubility 
(187.33 ± 1.40 mg/gm) and the smallest droplet size 
(20.9 ± 0.46 nm) compared with other formulations. 
However, this formula demonstrated poor flow properties 
revealed by its typically low calculated intrinsic viscosity 
(ηi) of 11.87 ± 0.72 poise. Therefore, formula G40 was 
further modified using 0.50% w/w of Carbopol® 940 as 
a rheology modifier to produce G41. The addition of this 
polymer increased the calculated intrinsic viscosity of the 
latter formula almost 14-fold compared with the former 
one. Also, formula G41 showed superior flow properties 
(ηi = 148.00 ± 7.36 poise) relative to that of the reference 
chosen (ηi = 122.98 ± 2.44 poise). The pH of Carbopol® 
940 aqueous dispersion was kept constant at a value of 7.4 
using TEA, which was previously reported to have a positive 
influence on the gelling and swelling characteristics of the 
Carbopol® resins.37–39 This can in turn improve the rheology-
modification properties of these polymers. Despite a possible 
reduction in active ingredient permeation properties, the 
polymer provides more resistance toward drug movement 
through the polymer-gel network. Therefore, the release 
profile of both formulations (G40 and G41) was evaluated 
and compared with that of the reference.
Figure 1 and Table 2 show the release profile of formulae 
G40, G41, and the reference formula and their calculated 
permeability parameters, respectively. Overall, it is apparent 
that formula G40 demonstrated faster and higher release 
profile compared with Nurofen® 5% Gel after 8 hours. 
Formula G41 had a higher drug transport profile than that 
of the reference over the first 3 hours of the experiment (the 
pre-steady state period). After 4 hours, the quantity of drug 
released from both formulae was almost equal, with sub-
sequently higher ibuprofen release from Nurofen® 5% Gel 
upon attaining the steady state condition.
Diffusion of the drug incorporated into an o/w emulsion 
or nanoscaled emulsion system is affected by the partitioning 
of the drug between the internal oil phase and the external 
aqueous phase. This means that the drug must diffuse 
from the internal phase to the external phase where the 
drug molecules are free to be released. Hence, when drug 
solubility, the driving force for the enhancement of drug 
release, is increased in the external phase, it is likely that an 
improvement in its partitioning from the internal phase to 
the external phase is observed.
Based on our results, formula G40 (Carbopol®-free 
formula) showed higher fluidity compared with the other 
formulations tested. This makes ibuprofen thermodynamic 
activity and release from the oil phase and its subsequent 
partitioning into the aqueous phase easier and faster. 
No gel-forming additive is included in this formula, which 
is usually able to network and structure the external phase 
that impedes the free drug movement and penetration. The 
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Figure  1  Cumulative  mean  of  in  vitro  permeation  profiles  of  ibuprofen  from 
formulations g40, g41, and reference gel through rat skin. 
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  physical properties of this nanoscaled emulsion may posi-
tively influence ibuprofen permeation (very small droplets 
size).40 The POEs were found to have an occlusive effect 
that can induce the hydration of the skin combined with the 
hydration effect of aqueous phase leading to an increase in 
the porosity of the skin.25 Additional hydration of the stratum 
corneum augments drug permeation by loosening of the 
tightly-packed lipid lamellae.41 Nonionic surfactants, like 
Tween 80, were found to act as permeation enhancers through 
different skin models. They can disturb the lipid bilayer of the 
stratum corneum, making it a less effective barrier against 
the permeation of many drugs.42–44
By contrast, both formula G41 and the reference are 
gels in their composition since they contain Carbopol® 940 
and hydroxyethyl cellulose as gelling agents, respectively. 
Both polymers are swellable upon exposure to an aqueous 
  environment. Acrylic acid-based polymers are reported to 
have high swelling capabilities.45 Also, Nurofen® 5% Gel 
contains high concentrations of benzyl alcohol and isopropyl 
alcohol in its composition, which can act dually as preserva-
tives and penetration enhancers. As a result, the first three 
hours of the experiment showed a little higher ibuprofen 
release from formula G41 compared with the reference, 
which indicated a good release of the drug from the oil 
phase to the aqueous phase and thereafter a good   penetration. 
Higher ibuprofen penetration from this formula may be attrib-
uted to the effects of POEs, Tween 80, the physical properties 
of the preparation, and the incompletely formed Carbopol® 
940 gel network. Furthermore, ibuprofen solubility stud-
ies showed that its oil solubility increased drastically upon 
adding the surfactant (Tween 80) at all ratios used (data not 
shown). Similarly, ibuprofen aqueous solubility rose dramati-
cally when the pH of the aqueous solution increased, with the 
highest solubility in PBS pH 7.4. Thus, ibuprofen molecules 
are expected to be mainly integrated in the oil phase and at 
the oil–water interface.46 It is also suggested that ibuprofen 
diffusion to the external phase should be faster at PBS pH 7.4 
as its solubility in this buffer is about 5 and 38 times higher 
than in PBS pH 6.0 and 4.0, respectively. Therefore, the 
partition of ibuprofen from POEs to PBS pH 7.4 would also 
be expected to be about 5 and 38 times higher in PBS pH 
7.4 compared with PBS pH 6.0 and 4.0, respectively. Higher 
solubility and partitioning would be the driving force for 
the drug to be released to the external phase and transferred 
through the membrane at a faster rate.
These postulations were in a good correlation with what 
was reported by Hadgraft and Valenta.47 They found that a 
gradual increase in the pH value of the external phase of 
topical or transdermal preparations containing ibuprofen 
can influence its skin permeation. Another study also dem-
onstrated a 10-fold increase in the flux of several NSAIDs, 
including ibuprofen, upon a gradual increase in the pH value 
of the topical preparation.44 These studies assumed that 
enhancing the ionization of NSAIDs can lead to an increase 
in their ion pairing capabilities with the external components 
of skin just like different types of fatty acids. The produced 
ion-pairs are usually more lipophilic than the unjoined drug, 
which lead to an augmentation in drug penetration via the 
skin.48–50 Another hypothesis that explains the increased 
drug transfer is connected to the transfer rates of ionized 
drugs, which are predominantly higher at high pH values, 
through the ionic channels oriented into the lipid bilayer of 
the stratum corneum.47
The release patterns were inversed after 4 hours of the 
experiment. This effect may be attributed to excessive 
  Carbopol® 940 swelling which imparts excessive imped-
ance to ibuprofen transfer through the skin. This was further 
  confirmed by measuring the thickness of the samples present 
in the donor compartment. The thickness of formula G41 
was almost doubled as it increased from 3.4 mm to 6.1 mm, 
whereas the thickness of the reference formula remained 
unchanged at 3.5 mm.
Our aim was to formulate a pharmaceutically accept-
able nanoscaled emulsion with advanced flow and 
Table 2 Permeability parameters of evaluated formulations
Formulation Flux  
(μg/cm2 hr)
Percentage of  
ibuprofen permeated
Permeability  
coefficient (cm/hr)
Enhancement   
ratio
g40 10.62 ± 1.364a 25.64 ± 3.587 0.203 ± 2.6 × 10−5 1.66
g41 5.86 ± 0.259 14.06 ± 1.755 0.112 ± 4.9 × 10−6 0.92
g44 7.31 ± 1.142 18.77 ± 3.928 0.139 ± 2.2 × 10−5 1.15
g45 9.37 ± 2.036a 21.93 ± 2.867 0.134 ± 7.9 × 10−6 1.47
g46 7.02 ± 0.415 17.78 ± 0.558 0.179 ± 3.9 × 10−5 1.10
g47 8.72 ± 0.036a 22.35 ± 0.665 0.166 ± 6.9 × 10−7 1.37
Nurofen® 5% gel 6.38 ± 0.734 16.58 ± 3.325 0.122 ± 1.4 × 10−5 –
Notes: All data is presented as mean ± standard deviation (n = 3). aP , 0.05 versus Nurofen® 5% gel.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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penetration   properties compared with the reference   formula. 
Rheologically, formula G40 failed to achieve the pro-
posed tasks; on the other hand, formula G41 had overall 
  permeation properties that were less than that of the refer-
ence   formula. Therefore, further modification of this formula 
was required.
The modification of this formula involved the addition 
of two different types of penetration enhancers; namely, 
menthol and limonene. Table 1 shows the composition of 
the modified forms of formula G41 that were denoted as 
G44–G47. These formulae were prepared using the same 
procedure described previously. The single difference is that 
two different concentrations (5% and 10% w/w) of menthol 
or limonene were mixed initially with POEs to produce the 
oil phase. The nanoscaled emulsion preparation process was 
then performed using the very same aforementioned steps. 
At all concentrations used, these penetration promoters were 
found to have no effect on the retention time of the drug in 
the HPLC chromatogram.
Many studies have demonstrated the effectiveness of 
terpenes as penetration enhancers in general and menthol and 
limonene in particular.26 Therefore, menthol and limonene 
were used at two different concentrations to modify the 
nanoscaled emulsion (formula G41).
Figure 2 and Table 2 illustrate the release profile and the 
calculated permeation parameters of the reference formula 
and formulations G44–G47, respectively. Looking at these 
results, it can be seen that using 5% w/w of menthol in 
formula G44 and 5% w/w of limonene in formula G46 
improved the release or permeation properties of ibuprofen. 
All parameters related to these two formulations, including 
flux, cumulative amount of ibuprofen released, permeability 
coefficient, and enhancement ratio, were increased compared 
with formula G41 and the reference.
Nevertheless, the improvement in the flux value 
of   formulae G44 and G46 was statistically insignificant 
from formula G41 (enhancer-free formula) and the reference 
formula. On the other hand, higher concentrations of these 
promoters created an improvement in the release patterns 
of formulae G45 and G47 containing 10% w/w of menthol 
and limonene, respectively. Statistically, the flux values of 
formulae G45 and G47 were significantly (P , 0.05) higher 
than those of the reference, G41, G44, and G46, but not from 
that of   formula G40. In other words, 10% w/w of menthol 
or limonene as permeation promoters succeeded to improve 
ibuprofen transport across rat skin to a level that is higher than 
other formulations except for formula G40 (Carbopol®-free 
and enhancer-free nanoscaled emulsion). Therefore, it can be 
suggested that 10% w/w of these promoters is sufficient to 
disrupt or disorder rat skin fat layers allowing higher amounts 
of ibuprofen to pass through.
Formulations G40, G45, and G47 were further   evaluated 
by measuring their pharmacodynamic properties and com-
paring them to that of the reference.
Measurement of in vivo  
anti-inflammatory activity
From Figure 3, it is obvious that all formulae tested had 
a potent anti-inflammatory effect, since a significant 
(P , 0.05) difference was obtained compared with the 
  placebo formula at all time intervals. After 6 hours, for-
mulae G40, G45, and G47 demonstrated significantly 
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(P , 0.05) higher   anti-inflammatory activity compared 
with the   negative control and the reference formula, with 
the   strongest effect attained by formula G45. This can be 
explained on the basis that the flux values (steady state flux 
that was achieved after 4 hours) of formulations G40, G45, 
and G47 were   marginally higher compared with the refer-
ence formula, with an enhancement ratio of 1.66, 1.47, and 
1.37, respectively. Thus, the difference in the anti-inflam-
matory activity among these formulae and the reference 
was achievable only after some time when the amount of 
permeated ibuprofen was sufficient to produce a significant 
difference. Higher permeability indicates the presence of a 
higher amount of ibuprofen available to generate the anti-
inflammatory reaction at the area of injection.
Measurement of in vivo analgesic activity
This study showed a good correlation between the anal-
gesic and anti-inflammatory effects of all formulae tested. 
It was obvious from the data presented in Figure 4 that all 
formulations had a markedly (P , 0.001) higher analgesic 
effect compared with the placebo preparation. After 2 hours 
of observation, no significant difference in the analgesic 
activity was achieved amongst formulae G40, G45, G47, and 
the reference. As the time progressed, the analgesic activity 
of the produced nanoscaled emulsions (G40, G45, and G47) 
became significantly (P , 0.001) stronger than that of the 
reference and the control. These results were in tandem with 
the anti-inflammatory effects of these formulations whereby 
permeation of more ibuprofen could have been triggered 
after a certain period of time. As the amount of ibuprofen 
increases, its inhibition to the activity of   prostaglandins 
becomes more efficient. Prostaglandins play an important 
role in promoting the signs and symptoms of inflammation 
and in sensitizing terminal afferent C-fibers in the periphery 
and enhancing the response of these fibers to algesic stimuli 
resulting in hyperalgesia.51 The prevention of cyclooxy-
genase enzyme and prostaglandin synthesis can rapidly 
reverse hyperalgesia and pain induction.52 After 4 hours, 
the analgesic activity of ibuprofen in all formulations was in 
the following order: G45 . G47 . G40 . reference. This 
could be due to the size, solubility, partition coefficient, and 
change in permeability of ibuprofen from the nanoscaled 
emulsions.
Conclusion
POEs, Tween 80, and TEA aqueous solution pH 7.4 were 
suitable to formulate ibuprofen as a pharmaceutically accept-
able nanoscaled emulsion for topical delivery. The selected 
ratio was capable of containing the desired drug concentration 
employed topically. Carbopol-free formula G40 showed the 
highest drug-transport rate or permeation flux at steady state 
over the period of examination through full-thickness rat skin. 
This could be due to its minute droplet size, synergistic effect 
attained by the formulation components, and the absence of 
gel-forming agents.
Carbopol® 940 at a concentration of 0.50% w/w was 
able to undermine the enhancing effects accomplished by 
the additives of formula G40 and reduced the release of 
ibuprofen from formula G41 to a point that is slightly less 
than the reference.
Lower concentrations (5% w/w) of the penetration 
promoters menthol and limonene were sufficient to increase 
ibuprofen flux to a level that is comparable to that of the 
reference. Higher percentages of these enhancers (menthol 
and limonene) equal to 10% w/w were effectively efficient 
to extend the transport of ibuprofen through rat skin to a 
position almost equal to that of formula G40 and higher than 
that of the reference. This is perhaps due to their elevated 
lipophilicity, skin lipid texture disrupting effect, and eutectic 
mixture formation.
The analgesic and anti-inflammatory effects of ibuprofen 
produced as nanoscaled emulsions in the form of   formulations 
G40, G45, and G47 were higher compared with the marketed 
reference (Nurofen® 5% Gel). The enhanced action may be 
ascribed to the combined effects of the small droplets size 
and composition of these formulae along with the increased 
drug solubility, partitioning into the aqueous phase of dosage 
form utilized, and permeability through the skin.
−100
−80
−60
−40
−20
0
20
24
%
 
c
h
a
n
g
e
 
o
f
 
p
a
i
n
 
t
h
r
e
s
h
o
l
d
 
Time (hr)
ControlN urofen Formula G40 Formula G47 Formula G45
*** *** *** *** **** ** ***
Figure  4  Analgesic  effects  of  various  formulations  comprising  ibuprofen,  applied 
topically on rat hind paw edema at 2 and 4 hours after administration of carrageenan. 
Note: All data is presented as mean ± standard error of the mean (n = 6).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
395
Permeation and pharmacodynamic properties of nanoscaled emulsion
Acknowledgments
The authors thank the Institute of Postgraduate Studies, 
Universiti Sains Malaysia, and the Biopharmacy Co-operative 
Center for providing financial assistance.
Disclosure
The authors report no conflicts of interest in this work.
References
  1.  Ventre M, Mollica F, Netti PA. The effect of composition and micro-
structure on the viscoelastic properties of dermis. J Biomech. 2009; 
42(4):430–435.
  2.  Hendriks FM, Brokken D, Oomens CWJ, Bader DL, Baaijens FPT. 
The relative contributions of different skin layers to the mechanical 
behavior of human skin in vivo using suction experiments. Med Eng 
Phys. 2006;28(3):259–266.
  3.  Kaur IP, Kapila M, Agrawal R. Role of novel delivery systems in 
developing topical antioxidants as therapeutics to combat photoageing. 
Ageing Res Rev. 2007;6(4):271–288.
  4.  Darlenski R, Sassning S, Tsankov N, Fluhr JW. Non-invasive in vivo 
methods for investigation of the skin barrier physical properties. Eur J 
Pharm Biopharm. 2009;72(2):295–303.
  5.  Marjukka Suhonen TA, Bouwstra J, Urtti A. Chemical enhancement 
of percutaneous absorption in relation to stratum corneum structural 
alterations. J Control Release. 1999;59(2):149–161.
  6.  Makrantonaki E, Zouboulis CC. The skin as a mirror of the aging process 
in the human organism – state of the art and results of the aging research 
in the German National Genome Research Network 2 (NGFN-2).   
Exp Gerontol. 2007;42(9):879–886.
  7.  Nakazawa H, Yamagishi A, Imai T, et al. Study on regional differences 
of stratum corneum structure in human skin by electron diffraction. 
Chem Phys Lipids. 2008;154:S27–S27.
  8.  Barry BW. Novel mechanisms and devices to enable successful 
  transdermal drug delivery. Eur J Pharm Sci. 2001;14(2):101–114.
  9.  Al-Saidan SM. Transdermal self-permeation enhancement of ibuprofen 
J Control Release. 2004;100(2):199–209.
  10.  Beetge E, Du Plessis J, Müller DG, Goosen C, Van Rensburg FJ. The 
influence of the physicochemical characteristics and pharmacokinetic 
properties of selected NSAID’s on their transdermal absorption. Int J 
Pharm. 2000;193(2):261–264.
  11.  Godwin DA, Wiley CJ, Felton LA. Using cyclodextrin complexation 
to enhance secondary photoprotection of topically applied ibuprofen. 
Eur J Pharm Biopharm. 2006;62(1):85–93.
  12.  Iervolino M, Raghavan SL, Hadgraft J. Membrane penetration enhance-
ment of ibuprofen using supersaturation. Int J Pharm. 2000;198(2): 
229–238.
  13.  Iervolino M, Cappello B, Raghavan SL, Hadgraft J. Penetration 
enhancement of ibuprofen from supersaturated solutions through human 
skin. Int J Pharm. 2001;212(1):131–141.
  14.  Stoye I, SchrDer K, Müller-Goymann CC. Transformation of a lipo-
somal dispersion containing ibuprofen lysinate and phospholipids into 
mixed micelles – physico-chemical characterization and influence on 
drug permeation through excised human stratum corneum. Eur J Pharm 
Biopharm. 1998;46(2):191–200.
  15.  Stott PW, Williams AC, Barry BW. Eutectic formulations of ibuprofen 
to enhance transdermal permeation. Eur J Pharm Sci. 1996;4(1): 
S147–S147.
  16.  Stott PW, Williams AC, Barry BW. Transdermal delivery from eutectic 
systems: enhanced permeation of a model drug, ibuprofen. J Control 
Release. 1998;50(1–3):297–308.
  17.  Santi P, Nicoli S, Colombo G, et al. Post-iontophoresis transport of 
ibuprofen lysine across rabbit ear skin. Int J Pharm. 2003;266(1–2): 
69–75.
  18.  Park E-S, Chang S-Y, Hahn M, Chi S-C. Enhancing effect of 
  polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int 
J Pharm. 2000;209(1–2):109–119.
  19.  Brown MB, Hanpanitcharoen M, Martin GP. An in vitro investiga-
tion into the effect of glycosaminoglycans on the skin partition-
ing and deposition of NSAIDs. Int J Pharm. 2001;225(1–2): 
113–121.
  20.  Sznitowska M, Janicki S, Dabrowska EA, Gajewska M. Physico-
chemical screening of antimicrobial agents as potential preservatives 
for submicron emulsions. Eur J Pharm Sci. 2002;15(5):489–495.
  21.  Pey CM, Maestro A, Solé I, González C, Solans C, Gutiérrez JM. 
Optimization of nano-emulsions prepared by low-energy emulsification 
methods at constant temperature using a factorial design study. Colloids 
Surf A Physicochem Eng Asp. 2006;288(1–3):144–150.
  22.  Cai H, An X, Shen W. Effects of the dispersed droplet sizes on the 
critical behavior of pseudobinary microemulsion. Chin Sci Bull. 2007; 
52(8):1139–1141.
  23.  Hickey S, Hagan SA, Kudryashov E, Buckin V. Analysis of phase 
diagram and microstructural transitions in an ethyl oleate/water/
Tween 80/Span 20 microemulsion system using high-resolution ultra-
sonic   spectroscopy. Int J Pharm. 2010;388(1–2):213–222.
  24.  Kreilgaard M. Assessment of cutaneous drug delivery using   microdialysis. 
Adv Drug Deliv Rev. 2002;54(1):S99–S121.
  25.  Keng PS, Basri M, Zakaria MRS, et al. Newly synthesized palm esters 
for cosmetics industry. Ind Crops Prod. 2009;29(1):37–44.
  26.  Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration 
enhancers. Drug Discov Today. 2007;12(23–24):1061–1067.
  27.  Dos Anjos JLV, Alonso A. Terpenes increase the partitioning and 
molecular dynamics of an amphipathic spin label in stratum corneum 
membranes. Int J Pharm. 2008;350(1–2):103–112.
  28.  Kang L, Yap CW, Lim PFC, et al. Formulation development of 
  transdermal dosage forms: Quantitative structure-activity relationship 
model for predicting activities of terpenes that enhance drug penetration 
through human skin. J Control Release. 2007;120(3):211–219.
  29.  Brain KR, Green DM, Dykes PJ, Marks R, Bola TS. The role of menthol 
in skin penetration from topical formulations of ibuprofen 5% in vivo. 
Skin Pharmacol Physiol. 2006;19(1):17–21.
  30.  Santoyo S, Arellano A, Ygartua P, Martn C. In vitro percutaneous 
absorption of piroxicam through synthetic membranes and abdominal 
rat skin. Pharm Acta Helv. 1996;71(2):141–146.
  31.  Abdullah GZ, Abdulkarim MF, Salman IM, et al. HPLC method 
modification and validation for quantification of ibuprofen. Int J Drug 
Delivery. 2010; In press.
  32.  Wagner H, Kostka K-H, Lehr C-M, Schaefer UF.   Interrelation of per-
meation and penetration parameters obtained from in vitro experiments 
with human skin and skin equivalents. J Control Release. 2001;75(3): 
283–295.
  33.  Larson DL, Lombardino JG. The topical anti-iflammatory effects of 
piroxicam in rodents. Agents Actions. 1980;10(3):246–252.
  34.  Sharma JN, Samud AM, Asmawi MZ. Comparison between plethys-
mometer and micrometer methods to measure acute paw oedema for 
screening anti-inflammatory activity in mice. Inflammopharmacology. 
2004;12(1):89–94.
  35.  Pénzes T, Blazsَ G, Aigner Z, Falkay G, Eros I. Topical absorption of 
piroxicam from organogels – in vitro and in vivo correlations. Int J 
Pharm. 2005;298(1):47–54.
  36.  Iwalewa EO, Iwalewa OJ, Adeboye JO. Analgesic, antipyretic, 
  anti-inflammatory effects of methanol, chloroform and ether extracts of 
  Vernonia cinerea less leaf. J Ethnopharmacol. 2003;86(2–3):229–234.
  37.  Lu G, Jun HW. Diffusion studies of methotrexate in carbopol and 
poloxamer gels. Int J Pharm. 1998;160(1):1–9.
  38.  Fresno MJC, Ramírez AD, Jiménez MM. Systematic study of the 
flow behaviour and mechanical properties of Carbopol® UltrezTM 
10   hydroalcoholic gels. Eur J Pharm Biopharm. 2002;54(3):329–335.
  39.  Lubrizol Advanced Materials Inc. Neutralizing Carbopol® and 
  Pemulen™ polymers in aqueous and hydroalcoholic systems. 
  Cleveland, OH: The Lubrizol Corporation; 2009.International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
396
Abdullah et al
  40.  Hadgraft J. Skin, the final frontier. Int J Pharm. 2001;224(1–2):1–18.
  41.  Walters KA, Hadgraft J, editors. Pharmaceutical Skin Penetration 
Enhancement. New York, NY: Marcel Dekker; 1993.
  42.  Okuyama H, Ikeda Y, Kasai S, Imamori K, Takayama K, Nagai T. 
  Influence of non-ionic surfactants, pH and propylene glycol on percu-
taneous absorption of piroxicam from cataplasm. Int J Pharm. 1999; 
186(2):141–148.
  43.  López A, Llinares F, Cortell C, Herráez M. Comparative enhancer 
effects of Span® 20 with Tween® 20 and Azone® on the in vitro 
  percutaneous penetration of compounds with different lipophilicities. 
Int J Pharm. 2000;202(1–2):133–140.
  44.  Shin S-C, Cho C-W, Oh I-J. Effects of non-ionic surfactants as perme-
ation enhancers towards piroxicam from the poloxamer gel through rat 
skins. Int J Pharm. 2001;222(2):199–203.
  45.  Abdullah GZ, Abdulkarim MF, Chitneni M, et al. Preparation and in 
vitro evaluation of mebeverine HCl colon-targeted drug delivery system. 
Pharm Dev Technol. April 30, 2010. [Epub ahead of print].
  46.  Liu R, editor. Water-insoluble Drug Formulation. New York, NY: CRC 
Press; 2000.
  47.  Hadgraft J, Valenta C. pH, pKa and dermal delivery. Int J Pharm. 2000; 
200(2):243–247.
  48.  Hadgraft J, Plessis JD, Goosen C. The selection of non-steroidal 
  anti-inflammatory agents for dermal delivery. Int J Pharm. 2000; 
207(1–2):31–37.
  49.  Hadgraft J, Walters KA, Wotton PK. Facilitated percutaneous 
  absorption: a comparison and evaluation of two in vitro models. Int J 
Pharm. 1986;32(2–3):257–263.
  50.  Green PG, Hadgraft J. Facilitated transfer of cationic drugs across a 
lipoidal membrane by oleic acid and lauric acid. Int J Pharm. 1987; 
37(3):251–255.
  51.  Veiga APC, Duarte IDG, Vila MNA, Motta PCGD, Tatsuo MAKF, 
Francischi JN. Prevention by celecoxib of secondary hyperalgesia 
induced by formalin in rats. Life Sci. 2004;75(23):2807–2817.
  52.  Zhang Y, Shaffer A, Portanova J, Seibert K, Isakson PC. Inhibition 
of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and 
prostaglandin E2 production. J Pharmacol Exp Ther. 1997;283(3): 
1069–1076.